Community-based provision of direct-acting antiviral therapy for hepatitis C: Study protocol and challenges of a randomized controlled trial

Background: To achieve the World Health Organization hepatitis C virus (HCV) elimination targets, it is essential to increase access to treatment. Direct-acting antiviral (DAA) treatment can be provided in primary healthcare services (PHCS), improving accessibility, and, potentially, retention in ca...

Full description

Bibliographic Details
Main Authors:	Wade, A., Doyle, J., Gane, E., Stedman, C., Draper, B., Iser, D., Roberts, S., Kemp, W., Petrie, D., Scott, N., Higgs, Peter, Agius, P., Roney, J., Stothers, L., Thompson, A., Hellard, M.
Format:	Journal Article
Published:	BioMed Central 2018
Online Access:	http://hdl.handle.net/20.500.11937/69783

Internet

http://hdl.handle.net/20.500.11937/69783

Community-based provision of direct-acting antiviral therapy for hepatitis C: Study protocol and challenges of a randomized controlled trial

Internet

Similar Items